A phase I, double-blind, placebo-controlled, single-dose, dose-escalation study of the safety, pharmacokinetics, and preliminary efficacy of XOMA 052 in subjects with type 2 diabetes mellitus.

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 03 Oct 2021

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

30 Sep 2009 Status changed from active, no longer recruiting to completed. Phase I trials of XOMA 052 are complete according to a XOMA media release.
14 Jul 2009 Interim results were reported in a Xoma media release; Xoma announced positive results from single and multiple dose subcutaneous arms of the trial; Placebo patients from both US and Sweden Phase I trials included.
09 Jun 2009 Results were presented at the American Diabetes Assocation 69th Annual Scientific Sessions.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com